DK1465923T3 - Corticotroprinafgivende faktor 2-receptoragonister - Google Patents

Corticotroprinafgivende faktor 2-receptoragonister

Info

Publication number
DK1465923T3
DK1465923T3 DK03731965T DK03731965T DK1465923T3 DK 1465923 T3 DK1465923 T3 DK 1465923T3 DK 03731965 T DK03731965 T DK 03731965T DK 03731965 T DK03731965 T DK 03731965T DK 1465923 T3 DK1465923 T3 DK 1465923T3
Authority
DK
Denmark
Prior art keywords
corticotroprine
receptor agonists
releasing factor
releasing
factor
Prior art date
Application number
DK03731965T
Other languages
English (en)
Inventor
Robert Joseph Isfort
Wieslaw Adam Mazur
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of DK1465923T3 publication Critical patent/DK1465923T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK03731965T 2002-01-16 2003-01-16 Corticotroprinafgivende faktor 2-receptoragonister DK1465923T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US34911702P 2002-01-16 2002-01-16
US37633702P 2002-04-29 2002-04-29
US38889502P 2002-06-14 2002-06-14
US41198802P 2002-09-19 2002-09-19
PCT/US2003/001454 WO2003062277A1 (en) 2002-01-16 2003-01-16 Corticotropin releasing factor receptor 2 agonists

Publications (1)

Publication Number Publication Date
DK1465923T3 true DK1465923T3 (da) 2007-07-02

Family

ID=27617822

Family Applications (2)

Application Number Title Priority Date Filing Date
DK03731965T DK1465923T3 (da) 2002-01-16 2003-01-16 Corticotroprinafgivende faktor 2-receptoragonister
DK03703867T DK1465921T3 (da) 2002-01-16 2003-01-16 Agonister til corticotropinfrigörelsesfaktor receptor-2

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK03703867T DK1465921T3 (da) 2002-01-16 2003-01-16 Agonister til corticotropinfrigörelsesfaktor receptor-2

Country Status (30)

Country Link
US (7) US7192924B2 (da)
EP (4) EP1465921B1 (da)
JP (3) JP4508649B2 (da)
KR (3) KR100758858B1 (da)
CN (3) CN1617887A (da)
AR (3) AR038142A1 (da)
AT (4) ATE334147T1 (da)
AU (2) AU2003205197B2 (da)
BR (3) BR0306826A (da)
CA (3) CA2470731C (da)
CY (1) CY1106133T1 (da)
DE (4) DE60313845T2 (da)
DK (2) DK1465923T3 (da)
ES (4) ES2269976T3 (da)
HK (1) HK1078095A1 (da)
IL (5) IL162431A0 (da)
MA (3) MA27591A1 (da)
MX (3) MXPA04006885A (da)
MY (1) MY140306A (da)
NO (3) NO20043366L (da)
NZ (3) NZ533598A (da)
PE (3) PE20030974A1 (da)
PL (3) PL373529A1 (da)
PT (2) PT1465921E (da)
RU (1) RU2294333C2 (da)
SA (3) SA03230564B1 (da)
SI (1) SI1465921T1 (da)
TW (3) TWI300442B (da)
WO (3) WO2003062269A2 (da)
ZA (1) ZA200404995B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040049009A1 (en) * 2000-09-22 2004-03-11 Klaus Eckart Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)
US7192924B2 (en) * 2002-01-16 2007-03-20 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists
WO2005103690A2 (en) * 2004-04-24 2005-11-03 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 2 (crhr2)
US20100034822A1 (en) * 2005-03-30 2010-02-11 Vega Masignani Haemophilus Influenzae Type B
US7815905B2 (en) 2006-01-27 2010-10-19 Research Development Foundation Methods of increasing insulin sensitivity or decreasing insulin secretion by administering corticotropin releasing factor receptor-2 inhibitors
WO2009046874A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Therapeutic combination of trh-potentiating peptide and stresscopin
KR20100056507A (ko) * 2007-09-11 2010-05-27 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드 ｐｒｏ－ｇｌｙ－ｔｈｒ－ｃｙｓ－ｇｌｕ－ｉｌｅ－ｃｙｓ－ａｌａ－ｔｙｒ－ａｌａ－ａｌａ－ｃｙｓ－ｔｈｒ－ｇｌｙ－ｃｙｓ의 용도
RU2010114038A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение адреномедуллина в качестве терапевтического средства для лечения избыточного ангиогенеза
EA201170647A1 (ru) * 2008-11-04 2011-12-30 Янссен Фармацевтика Нв Пептиды-агонисты crhr2 и их использование
EP2206726A1 (en) * 2009-01-08 2010-07-14 Universite Joseph Fourier Non-invasive tools for detecting vulnerable atherosclerotic plaques
MX2012005262A (es) * 2009-11-04 2012-09-28 Janssen Pharmaceutica Nv Metodo para tratar la insuficiencia cardiaca con petidos tipo estrescopina.
US9314506B2 (en) 2011-10-24 2016-04-19 Research Development Foundation Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors
AU2013221615B2 (en) * 2012-02-14 2018-02-22 The Regents Of The University Of California Systemic delivery and regulated expression of paracrine genes for cardiovascular diseases and other conditions
JOP20170153A1 (ar) 2016-07-15 2019-01-30 Lilly Co Eli نظائر urocortin-2 جديدة معدلة بحمض دهني لعلاج داء السكري وأمراض الكلى المزمنة
AU2017345785A1 (en) 2016-10-20 2019-05-16 Cortene Inc. Methods of treating diseases resulting from a maladapted stress response
CN110755434B (zh) * 2018-07-27 2022-03-15 中国医学科学院药物研究所 化合物palosuran防治骨骼肌萎缩等疾病的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235036A (en) * 1991-05-31 1993-08-10 The Salk Institute For Biological Studies Crf analogs
EP0860501A3 (en) 1994-06-14 1999-05-19 Neurocrine Biosciences, Inc. Corticotropin-releasing factor2 receptors
US5786203A (en) 1994-06-14 1998-07-28 Neurocrine Biosciences, Inc. Isolated nucleic acid encoding corticotropin-releasing factor2 receptors
US5824771A (en) * 1994-12-12 1998-10-20 The Salk Institute For Biological Studies Cyclic CRF agonists
US5663292A (en) 1994-12-12 1997-09-02 The Salk Institute For Biological Studies Cyclic CRF analogs
US5660824A (en) 1995-05-24 1997-08-26 Grabstein; Kenneth H. Muscle trophic factor
WO1997000063A2 (en) 1995-06-13 1997-01-03 The Salk Institute For Biological Studies Urocortin peptides
US5869450A (en) 1996-03-06 1999-02-09 The Regents Of The University Of California Anti-inflammatory compositions and method with corticotropin-releasing factor analogs
EP1305334B1 (en) 2000-08-04 2008-09-17 Research Development Foundation Urocortin proteins and uses thereof
US20020082409A1 (en) 2000-10-26 2002-06-27 Hsu Sheau Yu Stresscopins and their uses
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
US7192924B2 (en) * 2002-01-16 2007-03-20 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists

Also Published As

Publication number Publication date
PL373529A1 (en) 2005-09-05
US7462597B2 (en) 2008-12-09
BR0306878A (pt) 2004-10-26
CA2470656A1 (en) 2003-07-31
CN100391972C (zh) 2008-06-04
US20060025339A1 (en) 2006-02-02
KR100758857B1 (ko) 2007-09-14
US7608701B2 (en) 2009-10-27
US20030148956A1 (en) 2003-08-07
IL162529A0 (en) 2005-11-20
DE60313845T2 (de) 2008-01-31
ATE362488T1 (de) 2007-06-15
NO20043366L (no) 2004-10-06
AU2003237419B2 (en) 2006-04-13
US20100197579A1 (en) 2010-08-05
DK1465921T3 (da) 2006-11-27
PT1465921E (pt) 2006-12-29
ES2299701T3 (es) 2008-06-01
CN1617886A (zh) 2005-05-18
MA27590A1 (fr) 2005-11-01
DE60307044D1 (de) 2006-09-07
WO2003062269A2 (en) 2003-07-31
EP1724283B1 (en) 2008-06-18
IL196384A0 (en) 2011-07-31
KR20040082392A (ko) 2004-09-24
US7632933B2 (en) 2009-12-15
NZ533598A (en) 2007-03-30
WO2003062268A3 (en) 2003-11-27
SA03230565B1 (ar) 2006-10-31
MY140306A (en) 2009-12-31
EP1724283A3 (en) 2007-04-11
MA27592A1 (fr) 2005-11-01
KR20040082389A (ko) 2004-09-24
PL371364A1 (en) 2005-06-13
JP4508648B2 (ja) 2010-07-21
KR20040082390A (ko) 2004-09-24
CA2470743A1 (en) 2003-07-31
EP1465923B1 (en) 2007-05-16
DE60321730D1 (de) 2008-07-31
JP4489434B2 (ja) 2010-06-23
TW200302276A (en) 2003-08-01
TW200302277A (en) 2003-08-01
CN100475844C (zh) 2009-04-08
NO20043396L (no) 2004-10-06
WO2003062277A1 (en) 2003-07-31
BR0306838A (pt) 2005-04-05
AR038142A1 (es) 2004-12-29
EP1465923A1 (en) 2004-10-13
SA03230564B1 (ar) 2006-10-31
AU2003205197B2 (en) 2006-03-02
PE20030974A1 (es) 2003-12-26
NZ533600A (en) 2007-02-23
ATE398632T1 (de) 2008-07-15
AR038143A1 (es) 2004-12-29
JP2005522191A (ja) 2005-07-28
PL373139A1 (en) 2005-08-22
MXPA04006885A (es) 2004-12-06
JP2005521387A (ja) 2005-07-21
JP2005525101A (ja) 2005-08-25
CA2470731C (en) 2011-06-21
ES2309909T3 (es) 2008-12-16
CN1617887A (zh) 2005-05-18
HK1078095A1 (en) 2006-03-03
PE20030849A1 (es) 2003-12-01
IL162530A0 (en) 2005-11-20
US7897731B2 (en) 2011-03-01
US7192923B2 (en) 2007-03-20
WO2003062268A2 (en) 2003-07-31
BR0306826A (pt) 2005-09-06
WO2003062269A3 (en) 2003-11-06
ZA200404995B (en) 2005-06-29
PT1465923E (pt) 2007-08-06
SI1465921T1 (sl) 2006-10-31
IL197774A0 (en) 2009-12-24
ATE334147T1 (de) 2006-08-15
TW200302278A (en) 2003-08-01
NZ533599A (en) 2007-03-30
MA27591A1 (fr) 2005-11-01
ES2269976T3 (es) 2007-04-01
EP1465922B1 (en) 2008-01-09
CA2470731A1 (en) 2003-07-31
US20080004435A1 (en) 2008-01-03
IL162431A0 (en) 2005-11-20
US20030148958A1 (en) 2003-08-07
SA03230564A (ar) 2005-12-03
EP1465921A2 (en) 2004-10-13
PE20030747A1 (es) 2003-10-23
US7192924B2 (en) 2007-03-20
RU2294333C2 (ru) 2007-02-27
CA2470743C (en) 2011-12-13
NO20043371L (no) 2004-10-06
ATE383372T1 (de) 2008-01-15
CA2470656C (en) 2011-06-28
MXPA04006883A (es) 2004-12-06
CN1617885A (zh) 2005-05-18
DE60307044T2 (de) 2007-02-15
ES2287484T3 (es) 2007-12-16
MXPA04006884A (es) 2004-12-06
CY1106133T1 (el) 2011-06-08
EP1465921B1 (en) 2006-07-26
DE60318547T2 (de) 2008-12-24
SA03230565A (ar) 2005-12-03
KR100735586B1 (ko) 2007-07-04
KR100758858B1 (ko) 2007-09-14
EP1724283A2 (en) 2006-11-22
US6936585B2 (en) 2005-08-30
EP1465922A2 (en) 2004-10-13
DE60318547D1 (de) 2008-02-21
DE60313845D1 (de) 2007-06-28
US20090124793A1 (en) 2009-05-14
AR038144A1 (es) 2004-12-29
JP4508649B2 (ja) 2010-07-21
TWI300442B (en) 2008-09-01
RU2004124847A (ru) 2005-04-20
US20030148957A1 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
DK1446379T3 (da) Arylanilin-beta2-adrenergiske receptoragonister
IS7697A (is) Pýrimídýlsúlfónamíðafleiður sem miðlar flakkboðaviðtaka
IS2746B (is) Kínúklídínafleiður@sem@tengjast@múskarín@M@viðtökum
ATE388937T1 (de) Agonisten des cannabinoidrezeptors
ATE450505T1 (de) Cb 1 rezeptor inversagonisten
IL197774A0 (en) Corticotropin releasing factor 2 receptor agonists
ATE432282T1 (de) 2-alkinyl- und 2-alkenyl-pyrazolo-ä4,3-eü -1,2,4- triazolo-ä1,5-cü -pyrimidinadenosin a2a rezeptorantagonisten
FR2835321B1 (fr) Monture d'objectif
DK1487778T3 (da) Substituerede 4 aminocyclohexanoler
FI20031042A0 (fi) Puristusmekanismi
DE60303424D1 (de) D-Ring Halterung
FI20021674A0 (fi) Päällystyslaite
FR2851028B1 (fr) Dispositif d'eclairage
ITAN20020022V0 (it) Gancio regolabile per quadri
ATE491683T1 (de) Muskarine agonisten
FR2864203B1 (fr) Dispositif d' eclairage
FR2852042B1 (fr) Piece d'aretier
ZA200404994B (en) Corticotropin releasing factor 2 receptor agonists
DE50309974D1 (de) Löseeinheit
SI1465923T1 (sl) Agonisti receptorja 2 faktorja sproščanja kortikotropina
ITAP20030005A1 (it) L'indimenticabile soluzione
ITLU20020007U1 (it) "calendario-libro"
FI5656U1 (fi) Merkintäalusta
SE0202439D0 (sv) Anordning 1
SE0203152D0 (sv) Hållare